[Form 4] Blaize Holdings, Inc. Warrants Insider Trading Activity

Rhea-AI Filing Summary

Harminder Sehmi, Chief Financial Officer of Blaize Holdings, Inc. (BZAI), received a grant of 200,000 stock options on 09/01/2025. The options have an exercise price of $3.57, vest in eight substantially equal quarterly installments beginning on 12/01/2025, and expire on 08/31/2035. Following the reported transaction, 200,000 underlying shares of common stock are shown as beneficially owned directly.

The Form 4 was signed on 09/03/2025 and discloses this derivative award only; no cash purchase or sale price for the reported option grant is shown other than the stated exercise price.

Positive

• 200,000 stock options granted to the Chief Financial Officer on 09/01/2025
• Exercise price disclosed at $3.57 and expiration date of 08/31/2035
• Vesting schedule specified: eight substantially equal quarterly installments beginning 12/01/2025

Negative

• None.

Insights

Financial Analyst

TL;DR: CFO received a 200,000-option grant at $3.57 exercise price; vesting begins 12/01/2025.

The disclosed grant increases the CFO's potential equity stake pending vesting and exercise. The option terms—200,000 options, $3.57 strike, ten-year life to 08/31/2035 and staged vesting over eight quarterly installments starting 12/01/2025—are clearly reported. The filing does not include any cash transaction or other compensatory detail beyond the option award and the beneficial ownership shown as 200,000 shares following the grant.

Corporate Governance Expert

TL;DR: Insider disclosure is timely and standard for an executive option grant; vesting schedule is specified.

The Form 4 properly identifies the reporting person as the CFO and reports the derivative award with explicit vesting schedule and expiration. The filing appears to meet Section 16 reporting requirements by documenting the grant date (09/01/2025) and the signature date (09/03/2025). No other governance-related events or deviations are disclosed in the filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sehmi Harminder

(Last) (First) (Middle)

C/O BLAIZE HOLDINGS, INC.

4659 GOLDEN FOOTHILL PARKWAY, SUITE 206

(Street)

EL DORADO HILLS CA 95762

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Blaize Holdings, Inc. [ BZAI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$3.57	09/01/2025		A		200,000		(1)	08/31/2035	Common Stock	200,000	$0	200,000	D

Explanation of Responses:

1. The stock option vests in 8 substantially equal quarterly installments beginning on December 1, 2025.

	/s/ Harminder Sehmi	09/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Form 4 filed for BZAIW disclose?

The filing discloses a grant of 200,000 stock options to CFO Harminder Sehmi on 09/01/2025 with a $3.57 exercise price and 08/31/2035 expiration.

When do the options begin to vest for Harminder Sehmi?

The options vest in 8 substantially equal quarterly installments beginning 12/01/2025.

How many shares are shown as beneficially owned after the reported transaction?

The Form 4 reports 200,000 underlying shares of common stock as beneficially owned directly following the transaction.

What is the exercise price and expiration date of the options?

The exercise (conversion) price is $3.57 and the expiration date is 08/31/2035.

Who signed the Form 4 and when?

The Form 4 is signed by Harminder Sehmi on 09/03/2025.